14-day Premium Trial Subscription Sign Up For FreeGet Free

Cerecor Inc. Stock Forecast NASDAQ:CERC

Price Target and Analyst Ratings

Most Recent Rating

Cantor Fitzgerald is very positive about CERC and gave it a "Overweight" rating on June 04, 2021. The price target was set to $7.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-06-04 Overweight Initiated by Cantor Fitzgerald $2.90
2021-06-04 Overweight Initiated by Cantor Fitzgerald $2.90 $7.00
2021-04-27 Hold - Buy Upgraded by Maxim Group $2.84 $7.00
2021-04-26 Buy Initiated by Jefferies Financial Group $2.61 $4.00
2021-04-21 Hold - Buy Upgraded by Maxim Group $2.53 $7.00
2021-04-21 Hold - Buy Upgraded by Maxim Group $2.53
2021-04-20 Buy Initiated by Jefferies Financial Group $2.34 $4.00
2021-03-21 Buy Reiterated by Oppenheimer $3.21 $9.00
2020-06-07 Buy Reiterated by LADENBURG THALM/SH SH $2.73 $10.00
2020-05-13 Outperform Target Lowered by Oppenheimer $2.30 $11.00 → $10.00

CERC Stock Trend

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.22 is broken, it will firstly indicate a stronger fall rate.

Given the current short-term trend, the stock is expected to fall -17.50% during the next 3 months and, with a 90% probability hold a price between $1.83 and $2.52 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-30 $2.21 $2.63 $3.04
2021-10-01 $2.20 $2.62 $3.03
2021-10-04 $2.19 $2.61 $3.02
2021-10-05 $2.18 $2.59 $3.01
2021-10-06 $2.17 $2.58 $3.00
2021-10-07 $2.16 $2.57 $2.99
2021-10-08 $2.15 $2.56 $2.98
2021-10-11 $2.14 $2.55 $2.97
2021-10-12 $2.12 $2.54 $2.96
2021-10-13 $2.11 $2.53 $2.95
2021-10-14 $2.10 $2.52 $2.94
2021-10-15 $2.09 $2.51 $2.93
2021-10-18 $2.08 $2.50 $2.92
2021-10-19 $2.07 $2.49 $2.91
2021-10-20 $2.06 $2.48 $2.90
2021-10-21 $2.05 $2.47 $2.89
2021-10-22 $2.04 $2.46 $2.88
2021-10-25 $2.03 $2.45 $2.87
2021-10-26 $2.02 $2.44 $2.86
2021-10-27 $2.01 $2.43 $2.85
2021-10-28 $2.00 $2.42 $2.84
2021-10-29 $1.99 $2.41 $2.83
2021-11-01 $1.98 $2.40 $2.82
2021-11-02 $1.97 $2.39 $2.81
2021-11-03 $1.96 $2.38 $2.80
2021-11-04 $1.95 $2.37 $2.79
2021-11-05 $1.94 $2.36 $2.78
2021-11-08 $1.93 $2.35 $2.77
2021-11-09 $1.92 $2.34 $2.76
2021-11-10 $1.91 $2.33 $2.75

About Cerecor Inc.

Cerecor Cerecor Inc., a clinical-stage biopharmaceutical company, develops drugs to treat patients with neurological and psychiatric disorders. It develops CERC-301 that is in Phase II development stage for the adjunctive treatment of patients with major depressive disorder (MDD); CERC-501, which is in Phase II development stage for the adjunctive treatment of MDD, as well as to treat substance use disorders; and CERC-406 that is in preclinical stage to ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT